Inventor · disambiguated record
Sudha Visvanathan
Also filed as: VISVANATHAN SUDHA
2 granted patents·20 pending applications·4 citations·filing 2009–2024
46Inventor score
Top patents by PatentIndex Score
22 records- 0173US10507241B2Biomarkers useful in the treatment of IL-23A related diseasesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Dec 17, 2019·4 cites·10 claims
- 0272US2025304674A1Methods of treating inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0369US2024392019A1Anti-il-36r antibodies for the treatment of neutrophilic dermatosesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0465US2024409646A1Methods for the treatment and prevention of gppBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0564US12098207B2Anti-IL-36R antibodies for the treatment of pyoderma gangrenosumBOEHRINGER INGELHEIM INT·Filed 2021·Granted Sep 24, 2024·0 cites·8 claims
- 0664US2024317875A1Use of anti-cd40 antibodies for treatment of inflammatory conditionsBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0755US2020376117A1Biomarkers useful in the treatment of il-23a related diseasesBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 0854US2023049147A1Anti-il-36r antibodies for the treatment of a fibrotic conditionBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0952US2020299378A1Methods of treating diseasesBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 1052US2022089759A1Use of anti-cd40 antibodies for treatment of inflammatory conditionsBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 1151US2019359701A1Methods of treating diseasesBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 1250US2017298126A1Methods of treating inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 1349US2018334501A1Methods of treating diseasesBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1449US2022010022A1Anti-il-36r antibodies for the treatment of atopic dermatitisBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 1548US2011251099A1SERUM MARKERS PREDICTING CLINICAL RESPONSE TO ANTI-TNFa ANTIBODIES IN PATIENTS WITH ANKYLOSING SPONDYLITISVISVANATHAN SUDHA·Filed 2009·Application pending·0 cites
- 1648US2020308271A1Methods of treating inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 1747US2018009887A1Methods of treating diseasesBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 1846US2022290239A1Biomarkers associated with anti-il-36r antibody treatment in generalized pustular psoriasisBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1945US2016304602A1Methods of treating diseasesBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 2035US2018105588A1Methods of treating diseasesBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 2127US2012178100A1Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic ArthritisWAGNER CARRIE·Filed 2010·Application pending·0 cites
- 2226US2017081402A1Methods of treating inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sudha Visvanathan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →